Patients’ Perspective on Participation in Care With or Without the Support of a Smartphone App During Radiotherapy for Prostate Cancer: Qualitative Study

BackgroundPatients with prostate cancer are often cared for as outpatients during radiotherapy, which can be an aggravating circumstance for patient participation. There is a need to evaluate whether an interactive smartphone app could enable participation in care, specifical...

Full description

Bibliographic Details
Main Authors: Hälleberg Nyman, Maria, Frank, Catharina, Langius-Eklöf, Ann, Blomberg, Karin, Sundberg, Kay, Wengström, Yvonne
Format: Article
Language:English
Published: JMIR Publications 2017-07-01
Series:JMIR mHealth and uHealth
Online Access:http://mhealth.jmir.org/2017/7/e107/
id doaj-50f9b85b3612413aaf9f580e635d93ef
record_format Article
spelling doaj-50f9b85b3612413aaf9f580e635d93ef2021-05-03T01:40:42ZengJMIR PublicationsJMIR mHealth and uHealth2291-52222017-07-0157e10710.2196/mhealth.6829Patients’ Perspective on Participation in Care With or Without the Support of a Smartphone App During Radiotherapy for Prostate Cancer: Qualitative StudyHälleberg Nyman, MariaFrank, CatharinaLangius-Eklöf, AnnBlomberg, KarinSundberg, KayWengström, Yvonne BackgroundPatients with prostate cancer are often cared for as outpatients during radiotherapy, which can be an aggravating circumstance for patient participation. There is a need to evaluate whether an interactive smartphone app could enable participation in care, specifically during treatment for prostate cancer. The interactive app (Interaktor) used in this study is developed in codesign with patients and health care professionals; it includes daily reports of symptoms, a risk assessment model, evidence-based self-care advice, along with the provision of immediate access to clinicians. ObjectiveThe aim of this study was to explore how patients with prostate cancer perceived their participation with or without the support of the smartphone app during radiotherapy. MethodsA total of 28 prostate cancer patients receiving adjuvant radiotherapy were interviewed about their perceived participation in their own care. All the patients interviewed in this study participated in an intervention study where the control group received standard care that comprised having access to a contact nurse to turn to with any concerns during their treatment. In addition to standard care, the patients in the intervention group received the app downloaded in a smartphone. The patients’ age ranged between 57 and 77 years; 17 patients used the smartphone app. The interviews were analyzed with directed qualitative content analysis. ResultsThe four dimensions of patient participation, which include mutual participation, fight for participation, requirement for participation, and participation in getting basic needs satisfied, were confirmed as valid perspectives in the interviews with the patients with prostate cancer, irrespective of whether they used the smartphone app. However, the patients who had used the smartphone app described it as a facilitating factor, especially for mutual participation. ConclusionsUsing innovative ways to communicate with patients, such as an interactive app for symptom management with contact with health care in real time, can successfully help achieve increased patient participation in care.http://mhealth.jmir.org/2017/7/e107/
collection DOAJ
language English
format Article
sources DOAJ
author Hälleberg Nyman, Maria
Frank, Catharina
Langius-Eklöf, Ann
Blomberg, Karin
Sundberg, Kay
Wengström, Yvonne
spellingShingle Hälleberg Nyman, Maria
Frank, Catharina
Langius-Eklöf, Ann
Blomberg, Karin
Sundberg, Kay
Wengström, Yvonne
Patients’ Perspective on Participation in Care With or Without the Support of a Smartphone App During Radiotherapy for Prostate Cancer: Qualitative Study
JMIR mHealth and uHealth
author_facet Hälleberg Nyman, Maria
Frank, Catharina
Langius-Eklöf, Ann
Blomberg, Karin
Sundberg, Kay
Wengström, Yvonne
author_sort Hälleberg Nyman, Maria
title Patients’ Perspective on Participation in Care With or Without the Support of a Smartphone App During Radiotherapy for Prostate Cancer: Qualitative Study
title_short Patients’ Perspective on Participation in Care With or Without the Support of a Smartphone App During Radiotherapy for Prostate Cancer: Qualitative Study
title_full Patients’ Perspective on Participation in Care With or Without the Support of a Smartphone App During Radiotherapy for Prostate Cancer: Qualitative Study
title_fullStr Patients’ Perspective on Participation in Care With or Without the Support of a Smartphone App During Radiotherapy for Prostate Cancer: Qualitative Study
title_full_unstemmed Patients’ Perspective on Participation in Care With or Without the Support of a Smartphone App During Radiotherapy for Prostate Cancer: Qualitative Study
title_sort patients’ perspective on participation in care with or without the support of a smartphone app during radiotherapy for prostate cancer: qualitative study
publisher JMIR Publications
series JMIR mHealth and uHealth
issn 2291-5222
publishDate 2017-07-01
description BackgroundPatients with prostate cancer are often cared for as outpatients during radiotherapy, which can be an aggravating circumstance for patient participation. There is a need to evaluate whether an interactive smartphone app could enable participation in care, specifically during treatment for prostate cancer. The interactive app (Interaktor) used in this study is developed in codesign with patients and health care professionals; it includes daily reports of symptoms, a risk assessment model, evidence-based self-care advice, along with the provision of immediate access to clinicians. ObjectiveThe aim of this study was to explore how patients with prostate cancer perceived their participation with or without the support of the smartphone app during radiotherapy. MethodsA total of 28 prostate cancer patients receiving adjuvant radiotherapy were interviewed about their perceived participation in their own care. All the patients interviewed in this study participated in an intervention study where the control group received standard care that comprised having access to a contact nurse to turn to with any concerns during their treatment. In addition to standard care, the patients in the intervention group received the app downloaded in a smartphone. The patients’ age ranged between 57 and 77 years; 17 patients used the smartphone app. The interviews were analyzed with directed qualitative content analysis. ResultsThe four dimensions of patient participation, which include mutual participation, fight for participation, requirement for participation, and participation in getting basic needs satisfied, were confirmed as valid perspectives in the interviews with the patients with prostate cancer, irrespective of whether they used the smartphone app. However, the patients who had used the smartphone app described it as a facilitating factor, especially for mutual participation. ConclusionsUsing innovative ways to communicate with patients, such as an interactive app for symptom management with contact with health care in real time, can successfully help achieve increased patient participation in care.
url http://mhealth.jmir.org/2017/7/e107/
work_keys_str_mv AT hallebergnymanmaria patientsperspectiveonparticipationincarewithorwithoutthesupportofasmartphoneappduringradiotherapyforprostatecancerqualitativestudy
AT frankcatharina patientsperspectiveonparticipationincarewithorwithoutthesupportofasmartphoneappduringradiotherapyforprostatecancerqualitativestudy
AT langiuseklofann patientsperspectiveonparticipationincarewithorwithoutthesupportofasmartphoneappduringradiotherapyforprostatecancerqualitativestudy
AT blombergkarin patientsperspectiveonparticipationincarewithorwithoutthesupportofasmartphoneappduringradiotherapyforprostatecancerqualitativestudy
AT sundbergkay patientsperspectiveonparticipationincarewithorwithoutthesupportofasmartphoneappduringradiotherapyforprostatecancerqualitativestudy
AT wengstromyvonne patientsperspectiveonparticipationincarewithorwithoutthesupportofasmartphoneappduringradiotherapyforprostatecancerqualitativestudy
_version_ 1721485804268683264